BFONX
Price
$22.73
Change
-$0.26 (-1.13%)
Updated
Nov 18 closing price
Net Assets
51.08M
VIGAX
Price
$243.53
Change
-$3.14 (-1.27%)
Updated
Nov 18 closing price
Net Assets
357.2B
Interact to see
Advertisement

BFONX vs VIGAX

Header iconBFONX vs VIGAX Comparison
Open Charts BFONX vs VIGAXBanner chart's image
Biondo Focus Investor
Price$22.73
Change-$0.26 (-1.13%)
VolumeN/A
Net Assets51.08M
Vanguard Growth Index Admiral
Price$243.53
Change-$3.14 (-1.27%)
VolumeN/A
Net Assets357.2B
BFONX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
BFONX vs. VIGAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFONX is a Hold and VIGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 357B vs. BFONX (51.1M). VIGAX pays higher dividends than BFONX: VIGAX (0.40) vs BFONX (0.20). BFONX was incepted earlier than VIGAX: BFONX (16 years) vs VIGAX (25 years). BFONX (1.80) is less costly to investors than VIGAX (0.05). BFONX is a more actively managed with annual turnover of: 14.00 vs. VIGAX (11.00). BFONX has a lower initial minimum investment than VIGAX: BFONX (1000) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 19.95 vs. BFONX (-9.66). VIGAX return over 5 years is better than : 100.53 vs. BFONX (-0.53).
BFONXVIGAXBFONX / VIGAX
Total Expense Ratio1.500.053,000%
Annual Report Gross Expense Ratio1.800.053,600%
Fund Existence16 years25 years-
Gain YTD6.88116.78341%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets51.1M357B0%
Annual Yield % from dividends0.200.4049%
Returns for 1 year-9.6619.95-48%
Returns for 3 years49.50111.8144%
Returns for 5 years-0.53100.53-1%
Returns for 10 years49.69337.6315%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXBF0.50N/A
+0.90%
NUREXONE BIOLOGIC INC
NDEKF23.90N/A
N/A
Nitto Denko Corp.
NEVIF0.04N/A
-0.23%
Nevis Brands Inc.
NLLSF0.23-0.01
-4.15%
Nel ASA
SNPHY10.18-0.50
-4.68%
Santen Pharmaceutical Co., Ltd.